Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Geron (GERN) EBITDA (2016 - 2025)

Historic EBITDA for Geron (GERN) over the last 16 years, with Q3 2025 value amounting to -$13.9 million.

  • Geron's EBITDA rose 5078.15% to -$13.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$63.1 million, marking a year-over-year increase of 6966.16%. This contributed to the annual value of -$173.7 million for FY2024, which is 1042.16% up from last year.
  • According to the latest figures from Q3 2025, Geron's EBITDA is -$13.9 million, which was up 5078.15% from -$12.5 million recorded in Q2 2025.
  • In the past 5 years, Geron's EBITDA ranged from a high of -$12.5 million in Q2 2025 and a low of -$69.3 million during Q2 2024
  • For the 5-year period, Geron's EBITDA averaged around -$34.9 million, with its median value being -$28.9 million (2021).
  • As far as peak fluctuations go, Geron's EBITDA crashed by 8569.85% in 2023, and later skyrocketed by 8203.74% in 2025.
  • Quarter analysis of 5 years shows Geron's EBITDA stood at -$31.0 million in 2021, then crashed by 35.4% to -$42.0 million in 2022, then dropped by 29.41% to -$54.3 million in 2023, then skyrocketed by 63.07% to -$20.0 million in 2024, then surged by 30.74% to -$13.9 million in 2025.
  • Its last three reported values are -$13.9 million in Q3 2025, -$12.5 million for Q2 2025, and -$16.7 million during Q1 2025.